The target price lets investors set an expected value for an asset, helping define buy or sell points.
Choose whether you would like to receive an alert for your Target Price.
The target price lets investors set an expected value for an asset, helping define buy or sell points.
This asset and the price you set will be removed from your target price list and this cannot be undone.
Congratulations! Your Target Price strategy has reached 5 alerts. Now take the next step: upgrade and unlock unlimited alerts to capture every market opportunity.
Unlock unlimited alerts
type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 12/19/2024 | 12/26/2024 | 1.17346000 |
| Dividends | 12/22/2023 | 12/27/2023 | 0.07106000 |
| Dividends | 12/20/2019 | 12/27/2019 | 0.01585000 |
| Dividends | 12/21/2018 | 12/27/2018 | 0.78406000 |
| Dividends | 12/22/2017 | 12/28/2017 | 0.57949000 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| CRNX | Stock | Healthcare | US$ 9.01 B | 4,59% | |
Apogee Therapeutics, Inc. Common Stock
|
APGE | Stock | Healthcare | US$ 10.22 B | 4,29% |
Oruka Therapeutics, Inc.
|
ORKA | Stock | Healthcare | US$ 6.59 B | 4,24% |
CG Oncology, Inc. Common stock
|
CGON | Stock | Healthcare | US$ 5.68 B | 3,77% |
| DNTH | Stock | Healthcare | US$ 4.80 B | 3,19% | |
|
Veradermics, Incorporated
|
MANE | Stock | Healthcare | US$ 4.88 B | 3,17% |
| DFTX | Stock | Healthcare | US$ 4.49 B | 3,08% | |
| TVTX | Stock | Healthcare | US$ 4.66 B | 3,00% | |
| EWTX | Stock | Healthcare | US$ 4.09 B | 2,74% | |
| RLAY | Stock | Healthcare | US$ 3.82 B | 2,59% | |
| AMLX | Stock | Healthcare | US$ 3.66 B | 2,58% | |
| ACAD | Stock | Healthcare | US$ 3.54 B | 2,45% | |
| XENE | Stock | Healthcare | US$ 3.70 B | 2,42% | |
| TARS | Stock | Healthcare | US$ 3.40 B | 2,20% | |
| DYN | Stock | Healthcare | US$ 3.46 B | 2,16% | |
| IDYA | Stock | Healthcare | US$ 3.12 B | 2,10% | |
| VRDN | Stock | Healthcare | US$ 2.85 B | 2,00% | |
| DNLI | Stock | Healthcare | US$ 3.35 B | 1,99% | |
|
Disc Medicine Inc.
|
IRON | Stock | Healthcare | US$ 3.70 B | 1,99% |
|
MBX Biosciences, Inc. Common Stock
|
MBX | Stock | Healthcare | US$ 2.65 B | 1,71% |
| ZLAB | Stock | Healthcare | US$ 2.73 B | 1,60% | |
| IMNM | Stock | Healthcare | US$ 2.40 B | 1,60% | |
|
KINGHERO
|
KH6_old | Stock | Other | US$ 599.96 M | 1,60% |
| CLDX | Stock | Healthcare | US$ 2.33 B | 1,55% | |
| BCRX | Stock | Healthcare | US$ 2.19 B | 1,53% | |
| XNCR | Stock | Healthcare | US$ 2.60 B | 1,48% | |
| GLPG | Stock | Healthcare | US$ 1.55 B | 1,44% | |
Palvella Therapeutics, Inc
|
PVLA | Stock | Healthcare | US$ 2.20 B | 1,43% |
| VERA | Stock | Healthcare | US$ 2.30 B | 1,43% | |
| VCEL | Stock | Healthcare | US$ 2.10 B | 1,37% | |
| SRPT | Stock | Healthcare | US$ 1.96 B | 1,31% | |
| AGIO | Stock | Healthcare | US$ 1.86 B | 1,29% | |
Zenas BioPharma, Inc. Common Stock
|
ZBIO | Stock | Healthcare | US$ 1.85 B | 1,24% |
Maze Therapeutics, Inc. Common Stock
|
MAZE | Stock | Healthcare | US$ 1.79 B | 1,17% |
| SLS | Stock | Healthcare | US$ 1.85 B | 1,16% | |
| STOK | Stock | Healthcare | US$ 1.78 B | 1,15% | |
|
Generate Biomedicines, Inc. Common Stock
|
GENB | Stock | Healthcare | US$ 1.76 B | 1,14% |
| NUVB | Stock | Healthcare | US$ 1.65 B | 1,09% | |
|
Kailera Therapeutics, Inc. Common Stock
|
KLRA | Stock | Healthcare | US$ 1.63 B | 1,09% |
Structure Therapeutics Inc. American Depositary Shares
|
GPCR | Stock | Healthcare | US$ 1.45 B | 1,01% |
| IMCR | Stock | Healthcare | US$ 1.55 B | 0,99% | |
| TSHA | Stock | Healthcare | US$ 1.33 B | 0,93% | |
Mineralys Therapeutics, Inc. Common Stock
|
MLYS | Stock | Healthcare | US$ 1.50 B | 0,91% |
|
LB Pharmaceuticals Inc Common Stock
|
LBRX | Stock | Healthcare | US$ 1.30 B | 0,89% |
| NKTR | Stock | Healthcare | US$ 1.31 B | 0,87% | |
|
TYRA
|
TYRA_old | Stock | Healthcare | US$ 903.02 M | 0,84% |
| CMPS | Stock | Healthcare | US$ 1.22 B | 0,84% | |
Rapport Therapeutics, Inc. Common Stock
|
RAPP | Stock | Healthcare | US$ 1.47 B | 0,80% |
| MNKD | Stock | Healthcare | US$ 1.20 B | 0,80% | |
| VOR | Stock | Healthcare | US$ 1.22 B | 0,75% | |
| IMTX | Stock | Healthcare | US$ 1.08 B | 0,74% | |
|
Seaport Therapeutics, Inc. Common Stock
|
SPTX | Stock | Healthcare | US$ 1.08 B | 0,72% |
| KURA | Stock | Healthcare | US$ 878.93 M | 0,62% | |
| RIGL | Stock | Healthcare | US$ 912.70 M | 0,60% | |
Alto Neuroscience, Inc.
|
ANRO | Stock | Healthcare | US$ 890.80 M | 0,59% |
| MGTX | Stock | Healthcare | US$ 914.33 M | 0,59% | |
| CRVS | Stock | Healthcare | US$ 826.91 M | 0,54% | |
| WVE | Stock | Healthcare | US$ 706.08 M | 0,46% | |
| OLMA | Stock | Healthcare | US$ 643.11 M | 0,45% | |
| SLDB | Stock | Healthcare | US$ 699.11 M | 0,45% | |
| DSGN | Stock | Healthcare | US$ 647.09 M | 0,44% | |
ArriVent BioPharma, Inc. Common Stock
|
AVBP | Stock | Healthcare | US$ 641.99 M | 0,44% |
| CADL | Stock | Healthcare | US$ 674.89 M | 0,44% | |
| FDMT | Stock | Healthcare | US$ 660.17 M | 0,43% | |
Bicara Therapeutics Inc. Common Stock
|
BCAX | Stock | Healthcare | US$ 592.91 M | 0,41% |
| ACRS | Stock | Healthcare | US$ 579.64 M | 0,39% | |
| GERN | Stock | Healthcare | US$ 693.87 M | 0,38% | |
|
Eliem Therapeutics Inc
|
ELYM | Stock | Healthcare | US$ 342.68 M | 0,37% |
| FLGT | Stock | Healthcare | US$ 532.97 M | 0,36% | |
|
Neurogene Inc
|
NGNE | Stock | Healthcare | US$ 533.70 M | 0,35% |
Delcath Systems Inc
|
DCTH_old | Stock | Healthcare | US$ 98.93 M | 0,33% |
Oculis Holding AG Ordinary shares
|
OCS | Stock | Healthcare | US$ 448.36 M | 0,30% |
| RLMD | Stock | Healthcare | US$ 455.48 M | 0,30% | |
Zura Bio Limited Class A Ordinary Shares
|
ZURA | Stock | Healthcare | US$ 384.34 M | 0,26% |
| ALT | Stock | Healthcare | US$ 396.82 M | 0,26% | |
| CCCC | Stock | Healthcare | US$ 394.91 M | 0,25% | |
| ALLO | Stock | Healthcare | US$ 411.13 M | 0,25% | |
| RZLT | Stock | Healthcare | US$ 383.02 M | 0,25% | |
Tectonic Therapeutic, Inc.
|
TECX | Stock | Healthcare | US$ 371.05 M | 0,24% |
|
AgomAb Therapeutics NV American Depositary Shares
|
AGMB | Stock | Healthcare | US$ 337.35 M | 0,23% |
Contineum Therapeutics, Inc. Class A Common Stock
|
CTNM | Stock | Healthcare | US$ 364.55 M | 0,22% |
| XFOR | Stock | Healthcare | US$ 321.24 M | 0,21% | |
| ENTA | Stock | Healthcare | US$ 302.03 M | 0,20% | |
| FULC | Stock | Healthcare | US$ 285.67 M | 0,19% | |
SAB Biotherapeutics Inc
|
SABS | Stock | Healthcare | US$ 283.88 M | 0,19% |
| ARCT | Stock | Healthcare | US$ 271.16 M | 0,18% | |
| IMRX | Stock | Healthcare | US$ 238.33 M | 0,15% | |
| IKT | Stock | Healthcare | US$ 206.51 M | 0,14% | |
|
Evommune, Inc.
|
EVMN | Stock | Healthcare | US$ 215.58 M | 0,14% |
| AKBA | Stock | Healthcare | US$ 201.12 M | 0,14% | |
Upstream Bio, Inc.
|
UPB | Stock | Healthcare | US$ 185.67 M | 0,12% |
| BCYC | Stock | Healthcare | US$ 257.24 M | 0,12% | |
Sionna Therapeutics, Inc. Common Stock
|
SION | Stock | Healthcare | US$ 164.80 M | 0,11% |
| MGNX | Stock | Healthcare | US$ 147.15 M | 0,10% | |
Proteon Therapeutics Inc
|
PRTO_old | Stock | Other | US$ 18.52 M | 0,10% |
|
Compass Therapeutics Inc.
|
CMPX_old | Stock | Other | - | 0,09% |
| IMAB | Stock | Healthcare | US$ 533.68 M | 0,07% | |
| AVXL | Stock | Healthcare | US$ 116.80 M | 0,07% | |
| IMUX | Stock | Healthcare | US$ 103.70 M | 0,07% | |
| TENX | Stock | Healthcare | US$ 68.86 M | 0,04% |
Average Investor10 user rating
4.0
(0 people)
ALPS Medical Breakthroughs ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $182.22 million.
Over the past 12 months, ALPS Medical Breakthroughs ETF recorded a return of 20.49%, with its price trading between $44.13 and $70.79 during the same period.
The ETF is traded under the ticker SBIO.
The current price of SBIO is $53.34. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
SBIO is currently trading at $53.34, with a market capitalization of approximately $182.224.759,00. Over the past year, the ETF has delivered a 20.49% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in SBIO through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol SBIO, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, SBIO has returned -1.46%, and 20.49% over the past year.
If you were to purchase 100 shares of SBIO at the current price of $53.34, your total investment would be $5,334.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
